» Articles » PMID: 38961377

Surgical Treatment of Atrial Fibrillation in Elderly Patients Undergoing High Risk Cardiac Surgery

Abstract

Background: Evaluating outcomes of concurrent Cox-Maze procedures in elderly patients undergoing high-risk cardiac surgery.

Mehods: We retrospectively identified patients aged over 70 years with Atrial Fibrillation (AF) from 2011 to 2017 who had two or more other cardiac procedures. They were subdivided into two groups: 1. Cox-Maze IV AF ablation. 2. No-Surgical AF treatment. A propensity match score was used to generate a homogeneous cohort and to eliminate confounding variables. Heart rhythm was assessed from Holter reports or 12-lead ECG. Follow-up data was collected through telephone consultations and medical records.

Results: There were 239 patients. Median follow up was 61 months. 70 patients had Cox-Maze IV procedures (29.3%). Demographic, intra- and post-operative outcomes were similar between groups although duration of pre-operative AF was shorter in Cox-Maze group (p = 0.001). There was no significant 30-day mortality difference in propensity matched cohorts (n = 84. P = 0.078). Sinus rhythm at annual and latest follow-up was 84.9% and 80.0% respectively in Maze group - 160 patients (66.9%) were alive at long-term follow-up with good survival outcomes in Cox Maze group. There was a high proportion of patients in NYHA 1 status in Cox-Maze group. No differences observed in freedom from stroke (p = 0.80) or permanent pacemaker (p = 0.33) between the groups.

Conclusions: Surgical ablation is beneficial in elderly patients undergoing high-risk surgery - promoting excellent long-term freedom from AF and symptomatic / prognostic benefits, without added risk. Therefore, surgical risk should not be reason to deny benefits of concomitant AF-ablation.

Clinical Trial Registration: Not required.

References
1.
Ngaage D, Schaff H, Barnes S, Sundt 3rd T, Mullany C, Dearani J . Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery?. Ann Thorac Surg. 2006; 82(4):1392-9. DOI: 10.1016/j.athoracsur.2006.04.004. View

2.
Gaynor S, Schuessler R, Bailey M, Ishii Y, Boineau J, Gleva M . Surgical treatment of atrial fibrillation: predictors of late recurrence. J Thorac Cardiovasc Surg. 2005; 129(1):104-11. DOI: 10.1016/j.jtcvs.2004.08.042. View

3.
Krahn A, Manfreda J, Tate R, Mathewson F, Cuddy T . The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98(5):476-84. DOI: 10.1016/S0002-9343(99)80348-9. View

4.
Wang B, Xu Z, Han L, Zhang G, Lu F, Song Z . Impact of preoperative atrial fibrillation on mortality and cardiovascular outcomes of mechanical mitral valve replacement for rheumatic mitral valve disease. Eur J Cardiothorac Surg. 2012; 43(3):513-9. DOI: 10.1093/ejcts/ezs213. View

5.
Lin H, Wolf P, Beiser A, Kase C, Benjamin E, DAgostino R . Stroke severity in atrial fibrillation. The Framingham Study. Stroke. 1996; 27(10):1760-4. DOI: 10.1161/01.str.27.10.1760. View